Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Pharma Limited has disclosed its upcoming schedule of analyst and institutional investor meetings as required under SEBI listing rules. Two meetings are planned: a conference with MACM India on 22nd May 2025, and the B&K Securities Annual Investor Conference on 28th May 2025. Both interactions will be held in Mumbai in person, in either group or one-on-one format with investors. The company has noted that these dates may change depending on exigencies on either side.

Likely market impact

This is a routine disclosure about upcoming investor engagements and does not carry any direct fundamental impact. The meetings may shape short-term analyst sentiment if material updates are shared during interactions.